Literature DB >> 16769386

The value of the metabolic autopsy in the pediatric hospital setting.

Linda M Ernst1, Neal Sondheimer, Matthew A Deardorff, Michael J Bennett, Bruce R Pawel.   

Abstract

OBJECTIVE: To determine the utility of the metabolic autopsy in the hospitalized pediatric patient. STUDY
DESIGN: This was a retrospective review of all metabolic autopsies performed at a large pediatric hospital over a 5-year period. Premortem clinical diagnoses were correlated with autopsy findings and results of postmortem testing.
RESULTS: Of the 23 metabolic autopsies performed, a metabolic disorder was diagnosed before death in 4 and after death by extensive studies initiated before death in 2. In the remaining 17 cases, postmortem samples were inadequate for subsequent enzymatic analysis in 2, a nonmetabolic explanation for symptoms was identified in 4, and no unifying diagnosis could be defined in 8. A metabolic disorder was diagnosed by postmortem tissue study in 3 of the 17 cases; in all 3 of these cases the patient died in the neonatal period after limited premortem investigation for primary lactic acidosis. For the 8 subjects who had undergone an extensive laboratory workup before death, in each case metabolic autopsy failed to establish a diagnosis.
CONCLUSIONS: In a small but significant percentage of cases (18%), the metabolic autopsy successfully identified an undiagnosed metabolic disease. However, metabolic autopsy following an extensive nondiagnostic clinical workup is unlikely to yield a specific metabolic diagnosis.

Entities:  

Mesh:

Year:  2006        PMID: 16769386     DOI: 10.1016/j.jpeds.2006.01.040

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  1 in total

1.  Feasibility of INTACT (INcisionless TArgeted Core Tissue) biopsy procedure for perinatal autopsy.

Authors:  S C Shelmerdine; J C Hutchinson; L Ward; T Sekar; M T Ashworth; S Levine; N J Sebire; O J Arthurs
Journal:  Ultrasound Obstet Gynecol       Date:  2020-05       Impact factor: 7.299

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.